Best treatments for major depressive disorder (depression)

Understanding major depressive disorder

"Major Depressive Disorder" is the clinical name for what most people simply call depression, and it is narrower than the everyday word. According to MedlinePlus (NLM), depression "is more than a feeling of being sad or irritable for a few days" - it is a serious mood disorder, and "to be diagnosed with depression, your symptoms must occur most of the day, nearly every day, for at least two weeks," with "one of the symptoms" being "a depressed mood or a loss of interest in most activities." StatPearls (NCBI Bookshelf) sets the DSM-5 bar at five symptoms drawn from nine: low mood, anhedonia, guilt or worthlessness, low energy, poor concentration, appetite change, psychomotor retardation or agitation, sleep disturbance, suicidal thoughts. The detail people most often miss: StatPearls states that a "History of a manic or hypomanic episode must be ruled out to make a diagnosis of MDD," because that history points to bipolar disorder, which is managed differently - so what looks like treatment-resistant depression is sometimes a missed manic history. The PHQ-9 is a screen, not a diagnosis; StatPearls notes it "scores 0 to 27, with scores of equal to or more than 10, indicate a possible MDD." Scale: NIMH estimates that in 2021, 21.0 million U.S. adults - 8.3% of all U.S. adults - had at least one major depressive episode, with prevalence highest among adults aged 18-25 (18.6%), and that in 2021 an estimated 61.0% of adults with a major depressive episode received treatment. This page is general information, not medical advice.

Frequently asked

What is the best medication for depression?

depression is major depressive disorder. There isn't a single "best" medication for everyone — The 2023 American College of Physicians living clinical guideline on adults in the acute phase of MDD splits its advice by severity. For moderate to severe MDD, ACP "recommends monotherapy with either cognitive behavioral therapy or a second-generation antidepressant as initial treatment" (strong recommendation; moderate-certainty evidence), and separately "suggests combination therapy with cognitive behavioral therapy and a second-generation antidepressant" as an option (conditional recommendation; low-certainty evidence). For mild MDD, the same guideline "suggests monotherapy with cognitive behavioral therapy as initial treatment" - therapy first, not a medicine. If an adequate dose of a second-generation antidepressant does not produce a response, ACP suggests either "switching to or augmenting with cognitive behavioral therapy" or "switching to a different second-generation antidepressant or augmenting with a second pharmacologic treatment." Every one of these is a shared decision with a prescriber; drug selection and dosing are theirs to make.. Compare every option ranked above by our independent recall-safety rating (not an efficacy measure); this is general information, not medical advice.

What treats major depressive disorder?

Our catalog lists 18 products that may treat major depressive disorder, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is fetzima.

What is the best-rated treatment for major depressive disorder?

By our independent recall-safety rating — not an efficacy measure — fetzima ranks highest among the products we list for major depressive disorder. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat major depressive disorder?

Treatments for major depressive disorder span FDA drug classes including serotonin and norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, atypical antipsychotic. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.